Epicardial Treatment of Atrial Fibrillation Using Cryoablation in an Acute Off-pump Sheep Model

Abstract

Background: The purpose of this study was to test the feasibi-lity and effectiveness of cryoablation therapy (SurgiFrost™ CryoCath, Endocare Inc., Irvine, California, USA) for linear epicardial treatment of atrial fibrillation in an acute off-pump sheep model. Methods: After thoracotomy, we performed epicardial cryoablation (2 min intervals at - 160 °C) with pacing electrodes positioned at the left atrial appendage (LAA), the pulmonary veins (PVs), the right atrial appendage (RAA), and the vena cava cranialis (VCC) in 8 sheep. Circular epicardial ablations were performed with online temperature measurement in the ascending aorta and in the esophagus. The sheep were sacrificed two hours after ablation procedure, and heart, lungs, and esophagus were retrieved for histological examination. Out of all 8 sheep, histo-pathological analysis was performed on the RAA and VCC in 6 sheep and on the CAA and PV in all 8 sheep. Results: Thin-walled structures such as PVs and VCC showed electrical isolation. No significant changes in temperature in the descending aorta and the esophagus were observed. There was evidence of extensive transmural alteration including vascular lesions, myocardial degeneration and necrosis as well as epi- and endocardial necrosis in the left atria in three of 8 cases, in the right atria in 5 of 6 cases, in the VCC in 6 of 6 cases, and in the PV in 5 of 8 cases. Mild lesions of the muscular layer of the esophagus were found in 7 of 8 cases. Conclusions: Epicardial cryoablation is not effective on thicker tissues like LAA and RAA due to the rewarming of the current blood flow. However, thin tissues like VCC and PV can be isolated. Further chronic studies are necessary to evaluate the potential for regeneration of adjacent structures.

Cryoablation - atrial fibrillation - surgery

References

• 1 Cameron A, Schwartz M J, Kronmal R A, Kosinski A S. Prevalence and significance of atrial fibrillation in coronary artery disease (CASS registry).  Am J Cardiol. 1988;  61 714-717
• 2 Ryder K M, Benjamin E J. Epidemiology and significance of atrial fibrillation.  Am J Cardiol. 1999;  84 131R-8R
• 3 Maglio C, Ayers G, Tidball A W. et al . Health care utilization and cost of care in patients with symptomatic atrial fibrillation.  Circulation. 1996;  94 (suppl) 1-169
• 4 Benjamin E J, Wolf P A, D'Agostino R B. et al . Impact of atrial fibrillation on the risk of death: the Framingham Heart Study.  Circulation. 1998;  98 946-952
• 5 Cox J L, Schuessler R B, D'Agostino H J . et al . The surgical treatment of atrial fibrillation: III. Development of a definitive surgical procedure. .  J Thorac Cardiovasc Surg. 1991;  101 569-583
• 6 Cox J L, Schuessler R B, Lappas D G. et al . An 8-year clinical experience with surgery for atrial fibrillation.  Ann Surg. 1996;  224 267-273
• 7 Sie H T, Beukema W P, Misier A R. et al . Radiofrequency modified MAZE in patients with atrial fibrillation undergoing concomitant valve surgery.  J Thorac Cardiovasc Surg. 2001;  122 212-215
• 8 Nitta T, Lee R, Schuessler R B. et al . Radial approach: a new concept in surgical treatment for atrial fibrillation. Concept, anatomic and physiologic bases and development of a procedure.  Ann Thorac Surg. 1999;  67 36-50
• 9 Arcidi J M, Millar R C. Evolution of the MAZE III procedure: are modifications necessary?.  Thorac Cardiovasc Surg. 1999;  47 (Suppl 3) 362-364
• 10 Haissaguerre M, Shah D C, Jais P. et al . Electrophysiological breakthroughs from the left atrium to the pulmonary veins.  Circulation. 2000;  102 2463-2465
• 11 Sueda T, Imai K, Ishii O, Orihashi K, Watari M, Okada K. Efficacy of pulmonary vein isolation for the elimination of chronic atrial fibrillation in cardiac valvular surgery.  Ann Thorac Surg. 2001;  71 1189-1193
• 12 Sueda T, Nagata H, Orihashi K, Morita S, Okada K, Sueshiro M. et al . Efficacy of a simple left atrial procedure for chronic atrial fibrillation in mitral valve operations.  Ann Thorac Surg. 1997;  63 1070-1075
• 13 Haissaguerre M, Jais P, Shah D C. et al . Right and left atrial radiofrequency catheter therapy of paroxysmal atrial fibrillaton.  J Cardiovasc Electrophysiol. 1996;  7 1132-1144
• 14 Robbins I M, Colvin E V, Doyle T P, Kemp W E, Loyd J E, McMahon W S. et al . Pulmonary vein stenosis after catheter ablation of atrial fibrillation.  Circulation. 1998;  98 1769-1775
• 15 Hindricks G, Kottkamp H, Hammel D. et al . Radiofrequency ablation of atrial fibrillation: Early clinical experience with a catheter-guided intraoperative approach.  Eur Heart J. 1997;  18 (suppl) 135
• 16 Hindricks G, Mohr F W, Autschbach R. et al . Antiarrhythmic surgery for treatment of atrial fibrillation: new concepts.  Thorac Cardiovasc Surg. 1999;  47 (Suppl. 3) 365-369
• 17 Gillinov M, Pettersson G, Rice T W. Esophageal injury during radiofrequency ablation of atrial fibrillation.  J Thorac Cardiovasc Surg. 2001;  122 1239-1240
• 18 Doll N, Borger M, Fabricius A. et al . Esophageal perforation during left atrial radiofrequency ablation: Is the risk to high.  J Thorac Cardiovasc Surg. 2003;  125 836-842
• 19 Dubuc M, Tanguay J F, Siois P. et al .Cryoablation produces less endocardial thrombus than RF ablation. AHA 2001
• 20 Lustgarten D. et al . Cryothermal ablation: Mechanism of tissue injury and current experience in the treatment of tachyarrhythmias.  Progr Cardiovasc Dis. 1999;  41 481